OKYO Pharma Ltd (LSE:OKYO, NASDAQ:OKYO) in a stock market statement noted that it will be collapsing its American Depositary Securities (ADS) ahead of its anticipated new listing of its ordinary shares on the Nasdaq Capital Market (effective Monday).
The ADS have been listed on Nasdaq since May 2022.